Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice

BACKGROUND: Lipids are known to play crucial roles in the development of life-style related risk factors such as obesity, dyslipoproteinemia, hypertension and diabetes. The first selective cannabinoid-1 receptor blocker rimonabant, an anorectic anti-obesity drug, was frequently used in conjunction w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chunxiu, Wei, Heng, van den Hoek, Anita M., Wang, Mei, van der Heijden, Rob, Spijksma, Gerwin, Reijmers, Theo H., Bouwman, Jildau, Wopereis, Suzan, Havekes, Louis M., Verheij, Elwin, Hankemeier, Thomas, Xu, Guowang, van der Greef, Jan
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096625/
https://www.ncbi.nlm.nih.gov/pubmed/21611179
http://dx.doi.org/10.1371/journal.pone.0019423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096625/
https://www.ncbi.nlm.nih.gov/pubmed/21611179
http://dx.doi.org/10.1371/journal.pone.0019423

Ejemplares similares